<?xml version="1.0" encoding="UTF-8"?>
<fig id="F1" fig-type="figure" orientation="portrait" position="float">
 <label>FIGURE</label>
 <caption>
  <p>Percentage of persons who had positive test results for HBsAg or anti-HCV who were retained at each stage of care
   <xref ref-type="fn" rid="FN1">*</xref> — Uzbekistan Hepatitis Elimination Program — Tashkent, Uzbekistan, December 6, 2019–March 15, 2020
  </p>
  <p content-type="fig-fn">
   <bold>Abbreviations:</bold> anti-HCV = hepatitis C virus antibody; HBsAg = hepatitis B surface antigen; HBV = hepatitis B virus; HCV = hepatitis C virus; POC = point-of-care.
  </p>
  <p content-type="fig-fn">* Treatment was initiated for 25.4% of all persons who had positive test results for HBsAg and 15.2% of all persons who had positive test results for anti-HCV.</p>
 </caption>
 <span class="long-desc" xmlns="http://www.w3.org/1999/xhtml">The figure is a bar graph showing percentages of persons who had positive test results for HBsAg or anti-HCV who were retained at each stage of care during December 6, 2019–March 15, 2020, through the Uzbekistan Hepatitis Elimination Program in Tashkent, Uzbekistan.</span>
 <graphic xlink:href="mm6934a3-F" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
